APPS hits its May 22 earnings call with short interest ticking back up after weeks of retreat, options traders leaning bullish despite a modest defensive nudge, and the stock sitting 17% higher than a month ago.
Short sellers reversed course this week. After falling from a mid-April peak near 14.2% of free float down to roughly 11.7%, SI nudged back up 1.8% over the past week to 11.72% — snapping a steady four-week unwind. Days to cover stand at 6.15, meaning any rapid covering would take time to execute. The ORTEX short score has climbed to 63.9, its highest reading of the past two weeks, and is now trending in the wrong direction for bulls heading into the print. That said, the lending market offers no sign of stress: cost to borrow is just 0.52% APR, and availability remains wide at 294% — nearly three shares available to borrow for every one currently shorted. This is not a squeeze setup; it is a moderately elevated short position that just reversed its retreat.
Options traders are sending a mildly more cautious signal than usual, but the overall lean is still bullish. The put/call ratio edged up to 0.30, roughly 1.5 standard deviations above its 20-day average of 0.28 — a small defensive tilt. But context matters: at 0.30, the PCR remains near the bottom of its 52-week range of 0.24 to 0.50. Options traders are not hiding; they are simply slightly less aggressively bullish than they were a fortnight ago. The stock has gained 6% on the week and 17% over the past month to $4.46, which explains some of the mild hedging.
The analyst picture is stale — the most recent consensus data is from November 2025, so it should be treated with caution. The mean price target on record was $8.75 against a current price of $4.46, implying significant upside on paper. The most recent move of note was B of A Securities upgrading to Neutral with a $5.50 target back in August 2025. With all analyst data more than six months old, the Street's current positioning around today's print is unclear. What is clear is that recent institutional activity has been modestly constructive: Vanguard added roughly 488,000 shares, Granahan added 763,000, and Goldman Sachs built a new 1.7 million-share position as of the Q1 filing period. On the insider side, the CFO sold 15,096 shares on May 6 at $3.98 — a small transaction, and all insider activity in the recent window has been selling, though none at a scale that suggests elevated conviction.
The last two earnings prints produced consistent negative reactions: a 6.9% drop on the day and roughly 7% lower over the following five sessions after February's release, and a 5.4% one-day fall with a sharper 19% five-day decline after November's print. Today's report tests whether the stock's month-long recovery — built in part on the Databricks AI partnership announced last week — has fundamental earnings to underpin it, or whether the pattern of post-print selling reasserts itself.
See the live data behind this article on ORTEX.
Open APPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
